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As a part of the process of agonist-induced desensi- 
tization, 1321N1 human astrocytoma cells lose up to 
95% of their &adrenergic receptors, as detected by '''I- 
hydroxybenzylpindolol ("'IHYP) binding, after 12-24 h 
of exposure to isoproterenol. In preconfluent cultures 
the loss of &receptors  is completely reversible upon 
removal of isoproterenol, with receptor levels reaching 
100% of control levels within 48-72 h.  Addition of cyclo- 
heximide (5 gg/ml) upon removal of agonist does not 
prevent  the recovery of receptors. After an initial 4-h 
lag, receptors accumulate in  the presence of cyclohex- 
imide until the same receptor level is reached that was 
present at  the onset of desensitization. Confluent cul- 
tures, which have a reduced number of receptors  per 
cell, recover @-receptors to only 60 to 70% of control 
levels following removal of isoproterenol. In addition, 
cycloheximide blocks the recovery of receptors in these 
cultures. The effects of cycloheximide on the accumu- 
lation of receptors during cell growth suggest that 
receptors are stable in preconfluent cultures and that 
turnover only occurs later when cultures are confluent. 
The data also indicate that long term exposure of cells 
to catecholamine results  in  a form of the 8-adrenergic 
receptor that is undetectable by '251HYP binding but, 
nonetheless, retains  its primary amino acid structure. 
The undetectable receptors  appear to be retained until 
agonist is removed, whereupon they become detectable 
by "'IHYP binding with a tl lz of about 36 h in the 
presence of cycloheximide. 
Catecholamine-induced desensitization of the P-adrenergic 
receptor-linked  adenylate cyclase occurs by a  multistep proc- 
ess in 1321N1 astrocytoma cells (1-3), S49 lymphoma cells (3), 
frog erythrocytes (4), and  certain C6 glioma cells (5). An early 
event in the process of desensitization results  in the "uncou- 
pling" of the 6-adrenergic  receptor from adenylate cyclase. In 
1321N1 astrocytoma cells this uncoupling is expressed as a 
selective loss of responsiveness of adenylate cyclase to cate- 
cholamines with no alteration  in  receptor  number as assessed 
by &receptor  antagonist (['251]iodohydroxybenzylpindolol) 
binding. The uncoupled receptor exhibits a 10-fold increase in 
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the  apparent Kd for the binding of isoproterenol (2, 3). This 
initial uncoupling reaction is readily reversible upon removal 
of the catecholamine agonist. Harden et al. (6) have reported 
that  short  term incubation of astrocytoma cells with cate- 
cholamines results  in an alteration  in the sedimentation prop- 
erties of particulate P-adrenergic receptors. The altered recep- 
tors no longer co-migrated with  adenylate cyclase on sucrose 
density gradients and were shown to be uncoupled from 
adenylate cyclase in terms of their agonist binding properties. 
It was proposed that receptors displaying these characteristics 
could exist in cytoplasmic vesicles resulting from an agonist- 
induced selective endocytosis similar to  the process proposed 
for internalization of other hormone-receptor complexes (7- 
10). 
Although no change in the number of P-adrenergic recep- 
tors occurs during short  term incubation of cells with isopro- 
terenol,  receptor  number is markedly reduced after 2-6 h of 
continued exposure to catecholamine. By 24 h, the degree of 
loss of receptors and  the loss of catecholamine responsiveness 
of adenylate cyclase are similar and usually of the order of 
90% or greater (3). In contrast to  the rapidly reversible nature 
of the initial uncoupling reaction, the recovery from long term 
desensitization is much slower (3). The  mechanismb) leading 
to agonist-induced alteration of P-receptor binding properties 
and  the  ultimate cellular destination of the altered  receptors 
remain unclear. The present study examines the fate of /3- 
adrenergic receptors lost during chronic exposure of 1321N1 
astrocytoma cells to catecholamines. 
EXPERIMENTAL  PROCEDURES 
Materials-All cell culture materials were obtained from commer- 
cial sources as previously reported (11). (ItL)-lsoproterenol-HCl, cyclo- 
heximide, ascorbic acid, and Hepes' were from Sigma. Carrier-free 
Na'251  was purchased from Amersham, and ~-[4,5-"H]leucine (30-50 
from Drs. D. Hauser and R. Berthold of Sandoz (Basel). All other 
Ci/mmol) was  from ICN. Hydroxybenzylpindolol was a generous gift 
reagents used were of analytical grade. 
Cell Culture Conditions-The 1321N1 human astrocytoma cells 
were maintained in Dulbecco's modification of Eagle's medium sup- 
plemented with 5% fetal bovine serum in an atmosphere of 92% air 
and 8% COZ at 37 "C in a humidified incubator. Cells  were  grown in 
the absence of antibiotics, and the medium was replenished every 2- 
3 days. Cells were subcultured by detaching the monolayer with a 
Hepes-buffered (pH 7.8) 0.05% trypsin solution. The trypsinization 
was previously shown to have no effect on /?-adrenergic receptor 
number (11). In all experiments, /?-adrenergic receptor number was 
tissue culture dishes (Falcon). All cells were seeded from 150-mm 
assessed in membrane fractions derived from cells grown  on  100-mm 
dishes that contained confluent cells which  were at least 7 days old. 
' The abbreviations used are: Hepes, 4-(2-hydroxyethyl)-l-pipera- 
zineethanesulfonic acid '''IIHYP, ['"I]iodohydroxybenzylpindolol. 
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These cells are  termed "long term"  cultures  and exhibit,ed less than 
optimal responsiveness to catecholamines (11). 
(It)-Isoproterenol-HCl was added  to all appropriate  incubations in 
a solution that contained sodium ascorbate (final concentration, 1 
mM) as an antioxidant. Fresh isoproterenol was added every 6-8 h 
during a  typical 12-24 h incubation with the drug. Sodium  ascorbate 
(final concentration, 1 mM) alone was added to control dishes. All 
drugs were prepared  as  fresh solutions, and fresh growth medium was 
added  to all the  dishes  prior  to  the  addition of the  drug. 
Broken Cell Preparations-Growth medium was aspirated from 
the dishes, and  each cell sheet was rinsed twice with 5 ml of ice-cold 
lysing buffer which  consisted of 1 mM Tris  (pH 7.8 a t  4 "C) and 0.5 
mM MgC12. The cells  were then swollen in 5 ml of lysing buffer for 10 
to 15 min and lysed by scraping the dishes with a rubber spatula. 
Each suspension of lysed cells  was  centrifuged for 20 min at 34,000 
X g in a Beckman J21C  centrifuge at  4 "C. The  resultant pellet  was 
resuspended in 0.3 ml of 0.25 M sucrose  and 5 mM MgClr in 50 mM 
Tris  (pH 7.8 a t  4 "C) and stored a t  -70 "C until assayed. Samples 
stored in this  manner showed no significant change in /?-adrenergic 
receptor binding properties  during  several  months of storage. 
/?-Adrenergic  Receptor Assay-Hydroxybenzylpindolol was iodi- 
nated,  and  the  radioactive  product, "'IHYP, was  purified chromato- 
graphically and used in assessing /?-adrenergic receptor density as 
previously  described in  detail (12-14). In  most  experiments "'IHYP 
(80,000 dpm, 70 PM) was incubated with  tissue (15 to 55 pg  of protein), 
20 mM Tris,  pH 7.5, 2 mM MgC12, 1 mM sodium ascorbate, and 140 
mM NaCl in a  volume of 0.25 ml. After  a 30-min incubation a t  37 "C, 
10 ml of 140 mM NaCl in 10 mM Tris buffer (37 "C, pH 7.5) was added 
to  each  assay  tube,  and  the  samples were rapidly filtered using 25- 
mm glass  fiber  fiiters (Schleicher  and  Schuell #30). Each filter  was 
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FIG. 1. Recovery of b-adrenergic receptors following long 
term exposure of 1321N1 cells to isoproterenol. Eight-day old 
cultures were trypsinized and seeded into 100-mm Falcon Integrid 
plastic tissue culture dishes at approximately 8.0 X IO? cells/cmz. 
(*)-Isoproterenol  (final concentration, 0.1 PM) was added  to cells a t  
48 h and 120 h postsubculture. Fresh isoproterenol was added ap- 
proximately 6 h after  the  initial  addition of the drug. After a 12-h 
incubation with  isoproterenol, the  drug was  washed out with three 5- 
ml washes of Hepes-buffered Eagle's minimum essential medium 
(agonist free). Subsequently, 10 ml of Dulbecco's medium plus 5 8  
fetal calf serum was added.  Membrane  fractions were prepared at   the 
indicated times  and  control (0) and isoproterenol (ZSO) washout (0, 
0) samples assayed for /?-adrenergic receptor content as described 
under "Experimental Procedures." The data represent specifically 
bound "'IHYP and  are  the  mean 2 S.E. of duplicate  determinations 
for 3 dishes at each  time point. The  data  are  representative of three 
similar experiments.  Data  are  presented  as  receptors  per mg of protein 
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FIG. 2. Scatchard analysis of '2SIHW binding. Saturation 
binding isotherms were generated with membranes derived  from 60- 
h control cultures (O), 72-h cultures which had been exposed to 
isoproterenol (0.1 p ~ )  for 12 h (m), and cultures which had been 
allowed to recover in  the presence (A) and  absence (0) of cyclohexi- 
mide foIlowing a 12-h exposure to isoproterenol. The cycloheximide- 
recovered cultures (A) were taken 72 h after isoproterenol washout 
and  addition of cycloheximide (ie.  144 h postsubculture), while the 
cultures which  recovered without cycloheximide (0) were taken 24 h 
after  isoproterenol  washout (i.e. 96 h postsubculture). Approximately 
20 pg  of protein was incubated with  various concentrations (5 to 200 
pM) of '"IHYP, and  the  amount of radioligand  specifically  bound at  
each  concentration was determined. The  data  are  plotted  as  the  ratio 
of the  amount of specifically bound ligand to  free ligand (ordinate) 
versus the amount of specifically bound ligand per mg of protein 
(abscissa). Data points are the means of triplicate determinations 
and  are  representative of two  experiments.  Lines represent  the  least 
squares fit. 
washed with an additional 10 ml of 10 mM Tris, pH 7.5, a t  37 "C. 
Nonspecific  binding  was  defined as  the  amount of "'IHYP bound in 
the  presence of 100 p~  isoproterenol.  Specific binding represented 80 
to 95% of the radioactivity retained by the filters. In some experi- 
ments,  tissue was incubated with  various concentrations (5 to 200 PM) 
of 'z51HYP, and  the  amount of radioligand specifically bound at  each 
concentration was determined as described  above. These  data were 
analyzed by the  method of Scatchard (15) to provide  values  for the 
number of receptors  and  the dissociation constant of '2"IHYP. 
Protein Assay-Protein concentration was determined by the 
method of Lowry et  al. (16) using bovine serum  albumin  as a standard. 
Data  Presentation  and Analysis-Assays were  routinely  carried 
out in duplicate  or  triplicate,  and, in all experiments, three  samples 
were assayed for each  data point. Data  are  presented  as  the  mean +. 
standard  error of specifically bound '""IYP. The  number of times a 
particular  experiment was repeated is provided in the figure  legends. 
RESULTS 
Recovery of P-Adrenergic Receptors Following  Long Term 
Exposure of Cultures to Isoproterenol-As we have previ- 
ously reported (11)  the expression of &adrenergic receptors 
during growth of 1321N1 cells in culture (Fig. 1) was depend- 
ent on cell density. The specific activity of receptors increased 
markedly during the first 60 h in culture, reaching a maximal 
level within 3 days (Fig. 1, upper panel). Following 2 days at 
this maximal level,  the number of receptors per cell declined 
as cell density increased past confluency. The decline in 
specific activity of receptors is a reflection of increases in the 
number of cells per culture at a time (ie.  > 100 h postsubcul- 
ture) when receptor number  per dish remains constant (Fig. 
1, upper and lower punels). 
Incubation of cells in the presence of 0.1 pM isoproterenol" 
The Concentration of isoproterenol (0.1 p ~ )  used  in  these experi- 
ments  was sufficient to  produce maximal loss of ,&receptors with  no 
effects  on cell viability. This  concentration of isoproterenol  produces 
maximal  elevation of cyclic AMP levels in these cells (I). 
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for 12 h results in a marked reduction in the number of 
receptors  with  no  apparent  alteration  in  the for lz5IHYP as 
determined by Scatchard  analysis (Fig. 2). Fig. 1 demonstrates 
that cultures which had lost 90-95% of their &adrenergic 
receptors during a 12-h incubation with isoproterenol were 
able  to recover receptors  after  removal of the isoproterenol. 
The  pattern  and  extent of recovery of /3-adrenergic receptors 
showed a dependence on cell density. Thus, after a 12-h 
exposure of sparse  cultures (48 h postsubculture)  p-adrenergic 
receptors  accumulated  rapidly  upon  removal of isoproterenol, 
reaching 100% of control receptor number within 48-72 h. 
More  dense  cultures (120 h postsubculture) recovered recep- 
- 
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FIG. 3. Effect of cycloheximide  on the expression of /3-adre- 
nergic receptors during growth of 1321N1 cells. Cells were 
seeded as described in Fig. 1 and treated with cycloheximide (final 
concentration, 5 pg/ml) at 48 h (O), 72 h (U), and 120 h (A) postsub- 
culture. Fresh growth medium and cycloheximide were added 48 h 
after  the initial addition. Control cultures (0) were not  treated with 
cycloheximide. Membrane fractions were isolated at the indicated 
times and assayed for &adrenergic receptors as described in Fig. 1 
and under “Experimental Procedures.” The  data are representative 
of two similar experiments. 
TABLE I
Effect of cycloheximide on 1321Nl cell growth 
Cells were seeded and  treated  as described in Fig. 4. All time points 
correspond to  the time points in Fig. 4. Cells from each dish were 
trypsinized and counted with an Electrozone/Celloscope (Particle 
Data, Inc.). The results are from one experiment and  are represent- 
ative of three similar experiments. 
Time Control washout minus washout plus Cyclohexi- 
Isoproterenol Isoproterenol 
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FIG. 4. Effect of cycloheximide on recovery of &adrenergic 
receptors  following  long  term  exposure of preconfluent  cul- 
tures to  isoproterenol. Cells were seeded as described in Fig. l. 
cultures with fresh drug added 6 h  later. After a 12-h incubation with 
(&)-Isoproterenol (final concentration, 0.1 pM) was added to 48-h 
isoproterenol (ISO). the dishes were washed with agonist-free medium 
as described in Fig. 1, and 10 ml of Dulbecco’s medium plus 5% fetal 
calf serum was added. Cycloheximide (CHm (final concentration, 5 
pg/ml) was added to some of the cultures (., U), while other  cultures 
(0) were  allowed to recover in the absence of cycloheximide. Control 
cultures (0) received only 1 mM ascorbate as described under “Ex- 
perimental Procedures.” After 24 h in the presence of cycloheximide 
some of the cycloheximide-treated cultures were washed free of 
cycloheximide (0) and allowed to recover in cycloheximide-free me- 
dium. Fresh cycloheximide and medium were added 48 h after the 
initial addition of the drug to the cycloheximide-treated cultures. 
Membrane fractions and assays were performed as described under 
“Experimental Procedures.” The data are representative of three 
similar experiments. 
tors to only 60-70% of control levels following removal of 
isoproterenol. 
Effect of Cycloheximide  on the  Expression of /3-Adrenergic 
Receptors in Culture-In an  attempt  to  estimate &adrenergic 
receptor  turnover  rates,  the effect of cycloheximide on recep- 
tor  content was examined. Addition of cycloheximide (final 
concentration, 5 ,ug/ml) to  preconfluent 1321N 1 astrocytoma 
cultures (ie.  48 h and 72 h postsubculture) produced  a marked 
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inhibition of the  accumulation of /?-adrenergic receptors ob- 
served  during  the initial stages of culture (Fig. 3). The con- 
centration of cycloheximide (5 pg/ml)  employed  was  found to 
cause a greater  than 85% inhibition of [3H]leucine incorpora- 
tion into 1321N1 cellular protein  (data  not  shown)  and a total 
inhibition of cell growth (Table I). Receptor levels appeared 
to  remain relatively constant  throughout  the  incubation  with 
cycloheximide; however, a slight increase in specific activity 
was  observed. This  appears  to be due  to a decrease  in  total 
protein  per  culture dish. Addition of cycloheximide to con- 
fluent  cultures (i.e. >lo0 h postsubculture)  resulted in  a 
gradual  decrease in ,&adrenergic receptor levels (Fig. 3) with 
time. Although cycloheximide inhibited cell division, cells 
were able  to recover and grow following a 24-h (Table I) or 
48-h (data not shown) exposure to the drug. It appears, 
therefore,  that  chronic exposure to cycloheximide (5 pg/ml) 
does not affect cell viability. 
Effect of Cycloheximide on  the Recovery of P-Adrenergic 
Receptors in Preconfluent Cultures-Preconfluent cultures 
(48 h postsubculture) were incubated  with 0.1 ~ L M  isoproterenol 
for 12 h such  that 90% of the  receptor  sites were lost (Fig. 4). 
Isoproterenol was subsequently washed out  and agonist-free 
medium added. Addition of cycloheximide (5 pg/ml) imme- 
diately following the removal of isoproterenol completely in- 
hibited the recovery of receptors for the fiist 4 h (Fig. 5 ) .  
However, after  this initial lag receptors  reappeared  even in 
the presence of cycloheximide albeit at a 50% reduction in 
rate (Figs. 4 and 5 ) .  This  reduction in rate is probably  due  to 
the fact that cycloheximide inhibits cell growth. Receptor 
content  continued  to increase in  the presence of cycloheximide 
until the cultures expressed the  same  number of receptors 
that were present at the  time  isoproterenol was  initially added 
(48 h post-subculture). When cycloheximide was removed, 
either 24 or 48 h after  its  addition,  the ,&adrenergic receptor 
levels rapidly increased to  control levels  (Fig. 4). 
Throughout the incubation with cycloheximide, protein 
synthesis was inhibited between 85-95% as assessed  by [3H] 
leucine incorporation  into trichloroacetic  acid-precipitable 
material. Cell growth  also was completely blocked by cyclo- 
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FIG. 5. Examination of early  time  points  during the recovery 
of 8-adrenergic  receptors following chronic  exposure of pre- 
confluent 1321N1 cells to  isoproterenol. The cells were seeded 
and treated exactly as described  in  Fig. 4. Preconfluent cultures were 
washed  free of isoproterenol following a 12-h incubation with the drug 
and allowed to recover either in the presence (W) or absence (0) of 
cycloheximide. Control cultures (0) were treated as described under 
“Experimental Procedures.” The data  are presented as receptors per 
dish and  are representative of three experiments. 
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FIG. 6. Effect of cycloheximide on the  recovery of 8-adre- 
nergic  receptors following long  term  exposure of confluent 
1321N1 cells to  isoproterenol. Cells were seeded as described in 
Fig. 1. Isoproterenol (ISO) (0.1 p ~ )  was  added to 120-h cultures and 
removed 12 h later as described in Fig. 1. Cycloheximide (CHX) (5 
pg/ml) was added to some of the isoproterenol washout cultures 
(O), and other cultures were allowed to recover in the absence of 
cycloheximide (0) as described in Fig. 4. Control cultures (0) were 
treated as described under “Experimental Procedures.” Membrane 
fractions were prepared at the indicated times and assayed for p- 
adrenergic receptor content as described under “Experimental Pro- 
cedures.” The data are representative of two similar experiments. 
heximide as shown  in Table I. The  time  coordinates of Table 
I  correspond to  the conditions in Fig. 4. Data in Table I  clearly 
show that  addition of cycloheximide at  60 h postsubculture 
blocks cell growth however, normal growth of cells resumed 
if cycloheximide  was  washed out 24 h (Table I) or 48 h (not 
shown)  after  its  addition. Although 10-20% of the cells were 
lost  during a 96-h  exposure to cycloheximide, the  majority of 
the cells remained  attached  to  the  culture dish and  appeared 
to  retain  their  normal morphology. 
The  initial 4-h  lag  observed (Figs. 4 and 5) in the presence 
of cycloheximide  was not readily apparent  in cells which  were 
allowed to recover  in the  absence of cycloheximide. However, 
it  should be noted  that  the  rate of receptor  accumulation in 
cells allowed to recover  in the  absence of cycloheximide in- 
cludes  both  the  rate of receptor  synthesis  due  to cell growth 
and  the  rate of recovery of lost ,&receptors. If the  contribution 
of cell growth to  the  rate of receptor accumulation is sub- 
tracted  from  the observed rate in cultures allowed to recover 
in the  absence of cycloheximide, a  4-h  lag is apparent.  Thus, 
it s e e m  reasonable  to conclude that  receptor  synthesis  due  to 
cell growth masks the lag in recovery of lost receptors in 
cycloheximide-free cultures  and  that  the lag is  not  an  artifact 
Recovery of P-Adrenergic  Receptors 12285 
of cycloheximide treatment. 
Preconfluent  cultures  that expressed nearly  maximal  spe- 
cific activity of P-adrenergic  receptors (60 h postsubculture) 
and  had  lost  greater  than 90% of their  receptors  after a 12-h 
exposure to isoproterenol were still able to recover a full 
complement of receptors in the presence of cycloheximide 
following removal of isoproterenol  (data  not  shown).  In  addi- 
tion, the recovery of receptors after 24 h of exposure to 
isoproterenol is as rapid and as complete as after 12 h of 
exposure to agonist (data  not  shown). 
P-Adrenergic receptors  that  had recovered  in the presence 
of cycloheximide following removal of isoproterenol displayed 
an  affinity (Kd = 26 PM) for "IHYP similar  to  that of receptors 
that  had  recovered  without cycloheximide (Kd = 23 pM) and 
that of control cells (Kd  = 28 PM) (Fig. 2). Thus,  the increase 
in '"IHYP-binding sites in the presence of cycloheximide 
following removal of isoproterenol  was  not  due  to  an i crease 
in  affinity of the  receptor  for '"IHYP but was in fact  due  to 
an  increase in receptor  number. 
Effect of Cycloheximide on  the Recovery of P-Adrenergic 
Receptors  in Confluent Cultures-Since 1321N1 cells show  a 
marked reduction in /3-receptor number per cell after cell 
contact occurs, it was  proposed that confluent cultures  might 
have a reduced  capability of synthesizing new receptors,  or 
alternatively,  an  increased  degradative  capacity (1 1). There- 
fore, it  was of interest  to  determine  the effects of cyclohexi- 
mide  on  the recovery of P-adrenergic  receptors following long 
term exposure of confluent cultures to isoproterenol. Con- 
fluent  cultures (120 h postsubculture) were incubated  with 0.1 
~ L M  isoproterenol for 12 h such  that 90% of the  receptors were 
lost  (Fig. 6). In  contrast to preconfluent  cultures,  the recovery 
of ,&receptors following removal of isoproterenol was  blocked 
by cycloheximide in these cultures. Fig. 6 also shows that 
confluent cultures could not recover a full complement of 
receptors  even in the  absence of cycloheximide, with  receptor 
levels reaching only 70% of control levels. 
DISCUSSION 
Reversal of catecholamine-specific  desensitization appears 
to occur  by at  least  two different  processes. The  initial  uncou- 
pling reaction is readily  reversible ( t 1 / 2  = 7 min)  upon  removal 
of agonist (3). Furthermore, recovery from the uncoupled 
form of the receptor to the form capable of coupling to 
adenylate cyclase is  complete provided no  receptor loss has 
occurred. In  contrast,  our  earlier  studies  indicated  that recov- 
ery of lost  receptors  was negligible (3). It was  suggested that 
loss of receptors was  essentially  irreversible and  might be  a 
result of receptor internalization and degradation (1, 3, 6). 
The  present  studies  indicate  that  under  appropriate growth 
conditions  the ,&receptors lost  to  detection by '"IHYP bind- 
ing can in fact regain binding activity. The fact that lost 
receptors  are fully recovered  in  the presence of cycloheximide 
suggests that the primary structure of the receptor is con- 
served,  and,  therefore,  degradation  is  not involved  in  agonist- 
induced  receptor loss in  preconfluent  cultures. 
The effects of cycloheximide on  the  accumulation of recep- 
tors in culture reflect changes in receptor  accumulation  during 
growth. The  absence of receptor loss  in preconfluent  cultures 
during chronic exposure to cycloheximide (Fig. 3) suggests 
that  receptor  turnover  is negligible in such cultures. In analogy 
to insulin receptor  turnover in 3T3-Ll  mouse  adipocytes (17), 
it  is possible that a protein of very short half-life which is 
necessary for the normal degradation of P-receptors is lost 
during  the  incubation  with cycloheximide. Although we can- 
not completely rule  out  this possibility,  preliminary  observa- 
tions of /3-receptor turnover  in  the  presence of tunicamycin, 
an  inhibitor of dolichol pyrophosphate-mediated  protein gly- 
cosylation ( l a ) ,  also indicate essentially no  receptor turnover.:' 
Although tunicamycin (0.1 pg/ml) inhibits  protein  synthesis 
by only 15%, receptor accumulation is completely blocked, 
and  receptor  number  per  dish  remains  constant  throughout 
chronic exposure to  the drug. The small  increase  in specific 
activity  during  incubation of preconfluent  cultures with cyclo- 
heximide  (Fig. 3) probably  does not  represent presynthesized 
receptors in transit from intracellular pools to the plasma 
membrane, as has been  reported for the acetylcholine receptor 
(19). Instead,  the increase can be accounted  for by a loss in 
total cellular protein  during a time when receptor  number  per 
dish remains  constant. 
In  contrast  to  the  situation  in  preconfluent  cultures, cep- 
tor  turnover  apparently  does  take place  in  confluent cultures 
as indicated by the fact that receptor loss occurs in the 
presence of cycloheximide  (Fig. 3). One might  speculate  that 
cell contact could induce a degradation process  for ,&receptors 
which apparently  is  absent in  preconfluent  cultures.  Evidence 
from  this  study  that suggests degradation of the /3-receptor 
takes place  only  in  confluent cultures includes the following. 
(i)  Confluent  cultures  are  not  capable of recovering lost recep- 
tors in the presence of cycloheximide following exposure to 
catecholamines, whereas lost receptors in preconfluent cul- 
tures recover  in the presence of cycloheximide to  the level of 
receptors present at the  onset of desensitization. (ii)  In  the 
absence of cycloheximide,  confluent cultures which have  lost 
90% of their  receptors  can recover  only to 70% of control levels 
following removal of isoproterenol. On the  other  hand,  pre- 
confluent cultures recover a full complement of receptors 
following washout of isoproterenol.  (iii) Receptor  number  and 
specific activity in  confluent cultures show a  slight  decrease 
with  chronic exposure to cycloheximide, while preconfluent 
cultures show no  receptor  turnover.  The best current  inter- 
pretation of our  data  is  that /?-adrenergic receptor  degradation 
is significant  only  in late  or confluent cultures. 
Our  data suggest that  receptor recycling occurs  in 1321N1 
cells. The key questions  that  remain  to be  answered  concern 
the  mechanisms leading to  the loss of receptor-binding  sites 
and  the cellular  location of the lost receptors.  In  this regard  a 
great  deal is already known  concerning the down regulation 
of peptide  hormone  receptors.  Several  peptide  hormones  have 
been shown to be internalized after their binding to cell 
surface receptors (7-10, 20-22). However, there have been 
conflicting reports concerning the fate of the internalized 
hormone-receptor complexes. For example,  once  internalized, 
the epidermal growth factor (EGF)-receptor complex fuses 
with lysosomes where  the  entire complex is degraded (20, 23, 
24). In  contrast,  the  insulin-receptor complex does  not  appear 
to  be  degraded  as a single entity.  Krupp  and  Lane (25) have 
suggested that insulin degradation  and  receptor  degradation 
are separable processes. The results of some investigators 
suggest that certain receptors are spared from degradation 
entirely  and  may be recycled  back to  the cell surface  (see Ref. 
26). 
In  addition  to  the different mechanisms proposed for the 
regulation of EGF  and insulin receptor levels, there also have 
been  conflicting reports concerning the regulation of P-recep- 
tors.  In  agreement  with  the  results  in  our  study concerning 
@-receptor regulation in  preconfluent 1321N1 cultures, an 
inability of cycloheximide to  prevent  the  restoration of sensi- 
tivity  to  catecholamines  has been observed in frog erythro- 
cytes (27) and in Ehrlich  ascites cells (28). However, cyclo- 
heximide inhibited  the recovery of catecholamine-stimulated 
adenylate cyclase activity  in  BHK cells after desensitization 
with epinephrine (29). This  latter finding may be analogous 
R. C. Doss, unpublished results. 
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to  our  present  observations  that confluent 1321N1 cells are 
unable  to recover lost  &receptors  in  the presence of cyclohex- 
imide. The discrepancies observed between different cells and 
between preconfluent and confluent 1321N1 cells probably 
reflect  different mechanisms leading to agonist-induced loss 
of receptors. 
At  this  point we can only speculate  on  the  mechanisms for 
catecholamine-induced  receptor loss and  the  fate of the lost 
receptors.  There is no  direct evidence for /3-receptor internal- 
ization in 1321N1 cells, and in fact, enzymatic, reversible 
modifications (e.g. phosphorylation,  dephosphorylation; 
methylation,  demethylation) could explain our  data.  Previous 
reports  from  our  laboratory  have  shown  that agonist-induced 
“uncoupled”  receptors do not  co-migrate  with  plasma  mem- 
brane  marker enzymes on  sucrose  gradients (6). I t  was  sug- 
gested that  the uncoupled receptors  might exist  in  cytoplasmic 
vesicles as a result of selective endocytosis similar to the 
process  proposed for  internalization of other  hormone-recep- 
tor complexes (7-10). Such a mechanism  has been implicated 
recently for loss of membrane  p-receptors  during desensitiza- 
tion of frog erythrocytes (30, 31). Investigations  are  currently 
underway  to define the  mechanisms for the  regulation of p- 
receptor  synthesis  and processing  in 1321N1 astrocytoma cells. 
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